Nine Drug Companies Cut Prices Under Trump's Program. Here's What Actually Changes for Patients.

Nine pharmaceutical companies said they'd cut prices on some drugs through Trump's Most Favored Nation program. That's a headline worth checking. But before celebrating, ask the person rationing insulin what it means for them.

Here's what we know: price cuts on specific drugs sound like progress. And in isolation, they are. But they're also a symptom of a much deeper problem that no deal, no matter how many companies sign on, can actually solve.

The Real Story: A Bandage on a Broken System

The U.S. spends roughly twice what other wealthy countries spend on the same drugs. We pay more not because our drugs are better. We pay more because we let pharmaceutical companies set their own prices, then negotiate one deal at a time. It's like haggling at a farmers market when everyone else gets a bulk discount.

Nine companies cutting prices on some drugs is good news for people taking those specific medications. But it leaves untouched the core problem: tens of millions of Americans still can't afford the drugs their doctors prescribe. Medical debt remains the leading cause of personal bankruptcy in the wealthiest nation on earth.

A targeted price cut for Drug A doesn't help the person who needs Drug B, or the person with three prescriptions who can only afford one. It doesn't address why insulin, discovered a century ago, still costs ten times what it costs in Canada. It doesn't fix the fact that Americans ration medications at rates that would shock other developed nations.

What the Common Good Party Sees

We believe healthcare is the foundation everything else is built on. That means access to medicine shouldn't depend on which company happens to negotiate. Universal healthcare, where every American has coverage and medication is affordable for everyone, is the only way to actually solve this.

Individual price negotiations are fine. They're better than nothing. But they're not healthcare reform. They're not what keeps a family from choosing between insulin and rent.

Read the full Washington Post report.